NCT00376402View on ClinicalTrials.gov

Study of a Pandemic Influenza Vaccine in Elderly Participants

PHASE2CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

October 31, 2006

Study Completion Date

June 30, 2007

Conditions
Influenza
Interventions
BIOLOGICAL

H5N1 Pandemic Influenza Vaccine

Trial Locations (2)

5000

CMAX, a division of IDT Australia, Adelaide

6840

Princess Margaret Hospital for Children, Perth

All Listed Sponsors
lead

Seqirus

INDUSTRY

NCT00376402 - Study of a Pandemic Influenza Vaccine in Elderly Participants | Biotech Hunter | Biotech Hunter